Paul J Yazaki Selected Research

Neoplasm Antigens (Tumor Antigens)

1/2006

Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul J Yazaki Research Topics

Disease

43	Neoplasms (Cancer) 02/2024 - 12/2003
10	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 01/2003
7	Neoplasm Metastasis (Metastasis) 09/2020 - 12/2003
5	Prostatic Neoplasms (Prostate Cancer) 02/2020 - 06/2011
3	Breast Neoplasms (Breast Cancer) 02/2024 - 12/2009
3	Colonic Neoplasms (Colon Cancer) 09/2020 - 10/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2024 - 12/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 12/2018
1	Rectal Neoplasms (Rectal Cancer) 02/2023
1	Multiple Myeloma 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Residual Neoplasm 02/2020
1	Body Weight (Weight, Body) 02/2020
1	Adenocarcinoma 01/2020
1	Myeloid Leukemia (Leukemia, Myelocytic) 12/2019
1	Colitis 01/2015
1	Virus Diseases (Viral Diseases) 01/2015
1	Carcinoma (Carcinomatosis) 06/2011
1	Hematologic Neoplasms (Hematological Malignancy) 12/2003

Drug/Important Bio-Agent (IBA)

15	Carcinoembryonic AntigenIBA 01/2024 - 04/2004
15	AntigensIBA 02/2023 - 12/2003
13	AntibodiesIBA 01/2024 - 12/2003
9	Immunoglobulin FragmentsIBA 09/2017 - 12/2003
6	Monoclonal AntibodiesIBA 11/2023 - 05/2004
4	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2007
4	Coloring Agents (Dyes)IBA 01/2024 - 10/2017
4	Radioisotopes (Radionuclides)IBA 01/2021 - 12/2003
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 04/2017 - 07/2010
3	Immunoglobulin G (IgG)IBA 01/2024 - 07/2010
3	Glycoproteins (Glycoprotein)IBA 01/2021 - 07/2010
3	Sulfhydryl Compounds (Thiols)IBA 04/2017 - 01/2008
2	Interleukin-2 (IL2)IBA 02/2024 - 12/2022
2	Therapeutic UsesIBA 08/2023 - 01/2022
2	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 08/2023 - 01/2022
2	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2022 - 01/2021
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 01/2021
2	tumor-associated antigen 72IBA 09/2020 - 01/2020
2	Fluorescent Dyes (Fluorescent Probes)IBA 12/2018 - 04/2018
2	Lipid NanoparticlesIBA 09/2017 - 04/2017
2	LigandsIBA 04/2017 - 06/2011
2	Cysteine (L-Cysteine)FDA Link 04/2017 - 01/2004
1	Calcibiotic Root Canal SealerIBA 08/2023
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 08/2023
1	AdamantaneIBA 01/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2022
1	InterferonsIBA 12/2022
1	Muromonab-CD3 (Muromonab CD3)FDA Link 02/2022
1	RNA (Ribonucleic Acid)IBA 02/2022
1	SolutionsIBA 02/2022
1	ferroceneIBA 01/2022
1	daratumumabIBA 01/2021
1	IRDye800IBA 09/2020
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 02/2020
1	LipidsIBA 01/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020
1	Cell Surface ReceptorsIBA 12/2019
1	Green Fluorescent ProteinsIBA 04/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2017
1	auristatinIBA 09/2017
1	1,2-distearoylphosphatidylethanolamine (DSPE)IBA 04/2017
1	EstersIBA 04/2017
1	MicellesIBA 04/2017
1	maleimideIBA 04/2017
1	PolymersIBA 04/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2016
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 04/2016
1	MucinsIBA 01/2015
1	CTLA-4 AntigenIBA 01/2015
1	CEACAM1 ProteinIBA 01/2015
1	CytokinesIBA 01/2015
1	Bispecific AntibodiesIBA 03/2013
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2011
1	Lysine (L-Lysine)FDA Link 04/2011
1	IsotopesIBA 04/2011
1	Trastuzumab (Herceptin)FDA Link 12/2009
1	Immunoglobulins (Immunoglobulin)IBA 12/2009
1	AlbuminsIBA 02/2008
1	Humanized Monoclonal AntibodiesIBA 01/2008
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2006
1	indium- 111- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetraacetic acidIBA 07/2005
1	Indicators and Reagents (Reagents)IBA 05/2004
1	DisulfidesIBA 01/2004
1	Fluorouracil (Carac)FDA LinkGeneric 12/2003

Therapy/Procedure

17	Therapeutics 02/2024 - 01/2003
7	Radioimmunotherapy 01/2022 - 12/2003
3	Immunotherapy 12/2022 - 12/2009
2	Radiotherapy 02/2023 - 12/2003
2	Neoadjuvant Therapy 02/2023 - 08/2004
2	Drug Therapy (Chemotherapy) 08/2004 - 12/2003
1	Gastrectomy 01/2024
1	Precision Medicine 08/2023
1	Castration 02/2020
1	Aftercare (After-Treatment) 02/2020
1	Computer-Assisted Surgery (Image Guided Surgery) 12/2018
1	Laparotomy 10/2017